Perry Capital’s Allergan Inc AGN Stock Holding History

Perry Capital’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-1,667,625	Closed	-$282M	–	26
2014 Q2	$282M	Buy	+1,667,625	New	+$260M	7.8%	3

Other funds holding AGN

PSCM

Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Perry Capital's AGN Position: Q3 2014 in Review

Perry Capital sold out of Allergan Inc (AGN) in Q3 2014, closing a stake of 1,667,625 shares — an estimated $282M sold.

Perry Capital first reported a position in AGN in Q2 2014 and held it in 1 quarter. The position peaked at $282M in Q2 2014. 749 funds tracked by Wall St. Rank hold AGN as of Q3 2014.

Perry Capital reported no remaining Allergan Inc position as of Q3 2014 after selling out during the quarter.
Perry Capital sold 1,667,625 Allergan Inc shares in Q3 2014, an estimated $282M.
Perry Capital first reported a position in Allergan Inc in Q2 2014 and held it in 1 quarter.
Perry Capital's Allergan Inc position peaked at $282M in Q2 2014.
749 funds tracked by Wall St. Rank held Allergan Inc as of Q3 2014.

Based on Perry Capital's 13F filing for Q3 2014, filed 13 Nov 2014.